SP263 is a rabbit anti-human PD-L1 monoclonal antibody directed against the cytoplasmic region of human PD-L1 [33] that has been optimized and validated for use with FFPE NSCLC and HNSCC tissue samples. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.